Compare COMBAT DRUGS with KABRA DRUGS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

COMBAT DRUGS vs KABRA DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    COMBAT DRUGS KABRA DRUGS COMBAT DRUGS/
KABRA DRUGS
 
P/E (TTM) x 18.1 -10.7 - View Chart
P/BV x 4.1 - - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 COMBAT DRUGS   KABRA DRUGS
EQUITY SHARE DATA
    COMBAT DRUGS
Mar-21
KABRA DRUGS
Mar-20
COMBAT DRUGS/
KABRA DRUGS
5-Yr Chart
Click to enlarge
High Rs413 1,310.5%   
Low Rs181 3,386.8%   
Sales per share (Unadj.) Rs55.00-  
Earnings per share (Unadj.) Rs1.4-0.1 -1,016.4%  
Cash flow per share (Unadj.) Rs2.2-0.1 -3,449.3%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs13.6-0.1 -21,246.8%  
Shares outstanding (eoy) m10.104.39 230.1%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.5NM-  
Avg P/E ratio x21.3-13.5 -157.2%  
P/CF ratio (eoy) x13.4-28.5 -47.1%  
Price / Book Value ratio x2.2-29.0 -7.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m2988 3,706.4%   
No. of employees `000NANA-   
Total wages/salary Rs m4730-   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m5560-  
Other income Rs m60 2,808.7%   
Total revenues Rs m5620 244,382.6%   
Gross profit Rs m35-1 -6,972.0%  
Depreciation Rs m80 2,641.9%   
Interest Rs m120 117,000.0%   
Profit before tax Rs m21-1 -3,571.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m70-   
Profit after tax Rs m14-1 -2,338.3%  
Gross profit margin %6.3NM- 
Effective tax rate %34.50-   
Net profit margin %2.5NM- 
BALANCE SHEET DATA
Current assets Rs m22514 1,669.4%   
Current liabilities Rs m17314 1,199.4%   
Net working cap to sales %9.4NM- 
Current ratio x1.30.9 139.2%  
Inventory Days Days77NM- 
Debtors Days Days766NM- 
Net fixed assets Rs m1611 25,195.3%   
Share capital Rs m10144 230.1%   
"Free" reserves Rs m36-44 -81.2%   
Net worth Rs m1370 -48,882.1%   
Long term debt Rs m670-   
Total assets Rs m38714 2,732.4%  
Interest coverage x2.8-58.0 -4.9%   
Debt to equity ratio x0.50-  
Sales to assets ratio x1.40-   
Return on assets %6.7-4.1 -161.1%  
Return on equity %10.2212.8 4.8%  
Return on capital %16.2208.7 7.8%  
Exports to sales %0NM-  
Imports to sales %0NM-  
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m00-   
Fx outflow Rs m00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m180 -3,982.6%  
From Investments Rs m-31 -498.4%  
From Financial Activity Rs m40NA -23,464.7%  
Net Cashflow Rs m550-  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 45.9 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 54.1 100.0 54.1%  
Shareholders   12,796 7,424 172.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare COMBAT DRUGS With:   ADVANCED ENZYME TECHNOLOGIES  VAISHALI PHARMA   STRIDES PHARMA SCIENCE  AUROBINDO PHARMA  UNICHEM LAB  



Today's Market

LIC to Raise Stake in Kotak Bank, Tata Chemicals' EV Push, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a positive note yesterday. Benchmark indices trimmed early losses and ended in green backed by IT and healthcare stocks.

Related Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

Don't Sell these Stocks if the Market Falls(Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

How to Find Your Next 10-Bagger in this Market(Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

COMBAT DRUGS SHARE PRICE


Nov 29, 2021 (Close)

TRACK COMBAT DRUGS

  • Track your investment in COMBAT DRUGS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMBAT DRUGS - MAKERS LAB. COMPARISON

COMPARE COMBAT DRUGS WITH

MARKET STATS